Methamphetamine Does NOT Typically Cause Bradycardia, But CAN Cause T Wave Inversion
Methamphetamine use characteristically causes tachycardia and hypertension, not bradycardia—if you see bradycardia in a methamphetamine user, look for alternative explanations or complications. However, T wave inversion is a well-documented ECG abnormality associated with methamphetamine use.
Cardiovascular Effects of Methamphetamine
Expected Acute Presentation
According to AHA/ACC guidelines, the acute effects of methamphetamine are euphoria, tachycardia, hypertension, and arrhythmias 1. Methamphetamine stimulates release and blocks reuptake of dopamine and norepinephrine, creating a hyperadrenergic state 2. This produces:
- Increased heart rate (not decreased)
- Elevated blood pressure (both systolic and diastolic) 3
- Coronary vasospasm
- Enhanced platelet aggregation
- Arrhythmias
ECG Abnormalities in Methamphetamine Users
T wave inversion is a recognized ECG finding in methamphetamine users. Research demonstrates:
- Up to 70% of methamphetamine users have abnormal ECGs, with tachycardia being the most common finding 2
- ECG abnormalities occur in 71.7% of methamphetamine users compared to 32.1% of age-matched controls 4
- Lateral T wave inversion occurs significantly more frequently (3.8% vs 0.0% in controls) 4
- Additional abnormalities include left ventricular hypertrophy (26.4%), QTc prolongation (mean 436 ms), and inferior Q waves 4
QT interval changes are particularly important: Studies show QTc prolongation beyond 440 ms in 27.2% of methamphetamine users, which poses risk for ventricular arrhythmias including torsades de pointes 5. QT dispersion and Tp-e/QTc ratio are significantly elevated, indicating increased arrhythmic risk 6.
Clinical Implications
When You See Bradycardia
Bradycardia is NOT an expected finding with acute methamphetamine intoxication. If present, consider:
- Withdrawal phase - After the acute stimulant effects wear off
- Chronic cardiomyopathy - Long-term methamphetamine use causes myocarditis, necrotizing vasculitis, and dilated cardiomyopathy 1
- Conduction system disease - From chronic toxicity
- Concurrent medications or other substances
- Alternative diagnoses entirely
When You See T Wave Inversion
T wave inversion in methamphetamine users may indicate:
- Myocardial ischemia from coronary spasm or plaque rupture 1
- Chronic cardiomyopathy - Long-term use causes structural heart disease 1, 7
- Left ventricular dysfunction - Found in 38% of methamphetamine users undergoing echocardiography 4
- Pulmonary hypertension - Associated with chronic use 1, 4
Management Approach
Acute Presentation with Chest Pain
For methamphetamine users presenting with chest pain and ECG changes:
- Obtain 12-lead ECG immediately - Abnormalities are present in >70% of users 2
- Avoid beta-blockers during acute intoxication (Class III: Harm recommendation) - Risk of unopposed alpha-stimulation worsening coronary spasm 1, 8
- Use benzodiazepines alone or with nitroglycerin (Class IIa) for hypertension and tachycardia management 1, 8
- Calcium channel blockers and nitrates are preferred for coronary vasospasm 1, 9
Further Evaluation
All methamphetamine users with abnormal ECGs should undergo cardiac workup 4:
- Troponin levels (more specific than CK-MB due to rhabdomyolysis risk) 9
- Echocardiography to assess for cardiomyopathy, valvular disease, thrombus, and pulmonary hypertension
- Consider coronary angiography if ACS suspected with persistent symptoms
Critical Pitfall
Do not assume all ECG changes are benign training-related variants - Methamphetamine causes real structural heart disease. The presence of T wave inversion in multiple territories and deeper T waves (>0.183 mV) increases likelihood of underlying cardiomyopathy 10.
Long-Term Risks
Methamphetamine use is associated with:
- Increased risk of ventricular arrhythmias (HR 1.90) and mortality (HR 1.51) 11
- Chronic cardiomyopathy that persists beyond active use 7
- Premature cardiovascular mortality from accelerated atherosclerosis and structural damage 1, 7
The cardiovascular risk is not limited to the duration of active use - chronic pathology develops and increases risk of acute cardiac events even after cessation 7.